Search & Analyze

Poly Medicure Ltd.

HealthcareMedical Equipment/Supplies/Accessories

www.polymedicure.com BSE: 531768NSE: POLYMED

₹1,700.70BSE1.04%

16 Sep, 4:01 PM

₹1,700.70

₹17.30K Cr

54.91

5.44

10.94%

₹1,718.55

₹1,693.60

₹2,109.90

₹1,184.00

Customise metrics bar

Price Performance

Peer Comparison

Name
LENSKART LENSKART	677.40	179.78	1,17,820.60	0.00	228.43	273.43%	2,714.18	43.27%	12.55
Poly Medicure Ltd. POLYMED	1,700.70	54.91	17,302.40	0.21	85.27	-8.39%	525.38	30.30%	14.05
MOLBIO MOLBIO	1,312.65	90.80	15,126.98	0.00	52.74	320.28%	408.38	309.57%	19.79
3BBLACKBIO 3BBLACKBIO	1,291.00	20.03	1,108.02	0.39	8.98	-28.99%	33.49	50.62%	26.03
LAXMIDENTL LAXMIDENTL	195.15	34.68	1,073.90	0.00	10.32	23.83%	74.70	13.87%	24.97
GKB OPHTHA GKB	62.50	9.71	31.50	0.00	1.85	387.99%	33.04	2.28%	8.82

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	378.07	384.78	420.02	424.21	440.83	403.21	443.88	493.66	534.51	525.38
Expenses	281.61	280.98	304.83	309.81	321.23	296.96	329.20	382.47	424.11	400.28
	96.46	103.79	115.19	114.40	119.60	106.25	114.68	111.18	110.40	125.10
	25.51%	26.97%	27.42%	26.97%	27.13%	26.35%	25.84%	22.52%	20.65%	23.81%
	14.97	16.92	26.10	21.80	24.31	41.69	33.94	19.46	17.76	33.41
Interest	3.13	3.16	3.34	3.33	2.17	2.95	2.97	5.96	6.41	6.50
	16.08	19.53	20.71	21.37	21.17	23.37	24.93	28.76	38.23	36.25
	92.46	98.46	117.98	113.23	122.85	122.95	121.69	97.61	85.22	117.30
	26.07%	24.80%	25.87%	24.73%	25.25%	24.29%	24.56%	27.46%	23.68%	27.31%
	68.36	74.04	87.46	85.23	91.83	93.08	91.84	70.93	66.29	86.03
	7.12	7.71	8.63	8.41	9.06	9.19	9.06	7.00	6.54	8.49

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	927.34	1,119.77	1,381.06	1,677.15	1,886.84
	923.06	1,115.23	1,375.80	1,669.83	1,875.26
EXPENDITURE :
Increase/Decrease in Stock	-14.95	-23.65	10.80	-23.86	-7.64
Raw Material Consumed	296.55	345.37	382.51	471.68	496.81
Power & Fuel Cost	29.84	38.59	44.29	53.56	59.94
Employee Cost	163.62	202.75	245.91	301.53	402.26
Other Manufacturing Expenses	172.94	208.57	234.53	287.46	302.61
General and Administration Expenses	32.52	38.99	49.42	58.19	86.45
Selling and Distribution Expenses	15.68	20.99	27.25	43.35	63.03
Miscellaneous Expenses	11.86	16.23	21.08	22.20	33.20
	708.05	847.83	1,015.80	1,214.12	1,436.66
Operating Profit (Excl OI)	215.01	267.40	360.00	455.71	438.59
	37.90	36.19	58.75	89.13	126.93
	252.91	303.59	418.75	544.84	565.53
Interest	6.16	10.86	13.56	14.32	21.42
PBDT	246.75	292.73	405.19	530.52	544.11
	53.95	57.17	63.44	83.18	115.52
Profit Before Taxation & Exceptional Items	192.80	235.56	341.74	447.34	428.59
Exceptional Income / Expenses					-6.80
	195.24	237.49	344.27	452.52	427.47
Provision for Tax	48.74	58.21	86.01	113.96	106.74
	146.51	179.28	258.26	338.56	320.73
Extra items				0.00	0.00
Minority Interest					1.41
Consolidated Net Profit	146.51	179.28	258.26	338.56	322.14
Profit Balance B/F	304.17	399.04	527.75	730.85	1,013.64
Appropriations	450.67	578.32	786.01	1,069.41	1,335.78
Equity Dividend %	50.00%	60.00%	60.00%	70.00%	70.00%
	15.28	18.69	26.91	33.41	31.78
Adjusted EPS	15.28	18.69	26.91	33.41	31.78

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	47.95	47.97	47.99	50.66	50.68
Share Warrants & Outstandings	1.53	2.31	3.40	2.28	7.44
Total Reserves	1,038.01	1,191.35	1,418.67	2,712.71	3,048.05
Reserve excluding Revaluation Reserve	1,038.01	1,191.35	1,418.67	2,712.71	3,048.05
Revaluation reserve			0.00
	1,087.48	1,241.63	1,470.05	2,765.66	3,106.17
Minority Interest					43.07
Secured Loans	30.56	11.56	0.84		5.67
Unsecured Loans	7.56	5.94			46.42
Deferred Tax Assets / Liabilities	16.13	15.43	24.46	42.54	-15.67
Other Long Term Liabilities	4.43	4.74	5.82	4.43	52.68
Long Term Provisions	3.98	4.60	6.26	9.43	31.07
Total Non-Current Liabilities	62.68	42.28	37.38	56.40	120.16
Trade Payables	89.04	92.31	95.60	86.32	122.67
Other Current Liabilities	78.57	92.72	100.85	101.80	179.55
Short Term Borrowings	58.72	106.88	150.91	174.70	262.15
Short Term Provisions	0.35	59.25	77.23	94.88	102.17
Total Current Liabilities	226.68	351.17	424.59	457.71	666.53
Total Liabilities	1,376.83	1,635.07	1,932.02	3,279.77	3,935.93
Gross Block	818.46	1,018.82	1,311.18	1,596.05	2,476.07
Less: Accumulated Depreciation	334.23	384.47	444.38	511.73	782.08
Net Block	484.23	634.35	866.81	1,084.32	1,693.99
Capital Work in Progress	37.14	72.58	66.70	89.65	90.51
Non Current Investments	9.77	7.64	27.57	20.51	15.78
Long Term Investment	9.77	7.64	27.57	20.51	15.78
Long Term Loans & Advances	32.25	41.89	38.63	55.50	81.27
Other Non Current Assets	19.88	7.58	7.75	8.49	13.43
Total Non-Current Assets	593.40	770.52	1,017.05	1,269.89	1,903.19
Currents Investments	336.60	124.02	139.54	1,055.79	739.16
Inventories	168.36	208.65	221.03	285.57	433.84
Sundry Debtors	206.63	235.43	269.94	349.73	531.17
Cash and Bank	15.44	177.63	146.86	151.34	87.87
Other Current Assets	12.44	15.75	16.90	16.94	53.01
Short Term Loans and Advances	43.98	103.06	120.71	150.50	187.69
Total Current Assets	783.44	864.55	914.98	2,009.87	2,032.74
Net Current Assets (Including Current Investments)	556.76	513.39	490.39	1,552.17	1,366.21
Total Assets	1,376.83	1,635.07	1,932.02	3,279.77	3,935.93
Contingent Liabilities	69.24	69.07	113.16	77.12	50.21
Total Debt	125.27	146.43	169.97	177.65	341.62
	113.24	129.17	152.82	272.72	305.72
Adjusted Book Value	113.24	129.17	152.82	272.72	305.72

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	195.24	237.49	344.27	452.52	427.47
Adjustment	39.08	60.89	36.77	28.29	69.57
Changes In working Capital	-63.39	-49.46	-40.66	-155.34	-148.92
Cash Flow after changes in Working Capital	170.93	248.92	340.38	325.46	348.12
Cash Flow from Operating Activities	123.47	191.05	266.08	233.05	246.37
Cash Flow from Investing Activities	-85.33	-179.24	-240.94	-1,187.18	-225.38
Cash Flow from Financing Activitie	-35.34	-12.51	-20.15	950.51	20.15
Net Cash Inflow / Outflow	2.80	-0.70	4.99	-3.63	41.14
Opening Cash & Cash Equivalents	4.95	7.76	7.06	12.05	8.70
Effect of Foreign Exchange Fluctuations				0.27	1.38
Closing Cash & Cash Equivalent	7.76	7.06	12.05	8.70	51.23

Ratios

Valuation

54.91

5.44

30.65

8.66

31.09

313.97

Profitability

10.94

14.05

8.89

23.24

17.00

Leverage & Liquidity

0.11

3.05

20.96

Returns

0.21

0.52

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	66.03	62.56	62.44	62.44	62.44	62.42	62.42	62.42	62.42
	19.26	24.20	23.99	23.42	23.13	23.31	23.24	21.50	21.65
	14.72	13.24	13.57	14.15	14.44	14.27	14.34	16.08	15.94
	33.97	37.44	37.56	37.56	37.56	37.58	37.58	37.58	37.58
No. of Shareholders	36,852	38,352	60,686	65,583	71,142	64,400	67,750	73,414	73,643

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-08-14	AGM
2026-07-31	Board Meeting	Quarterly Results
2026-05-25	Ex Dividend	Rs.3.5000 per share(70%)Final Dividend	2026-08-28	2026-08-29

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareMedical Equipment/Supplies/Accessories

Poly Medicure Ltd. operates in the Healthcare sector under the Medical Equipment/Supplies/Accessories industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

14 members across the board and senior leadership

Devendra Mehta

Chairman

₹28.00 L

Mar '26

Jugal Kishore Baid

Non Independent & Non Executive Director

₹24.50 L

Mar '26

Vimal Bhandari

Non Executive Independent Director

₹25.00 L

Mar '26

Amit Khosla

Non Executive Independent Director

₹28.00 L

Mar '26

Ambrish Mithal

Non Executive Independent Director

₹24.00 L

Mar '26

Sonal Mattoo

Non Executive Independent Director

₹26.00 L

Mar '26

Himanshu Baid

Managing Director

₹18.10 Cr

Mar '26

Alessandro Balboni

Non Independent & Non Executive Director

₹24.00 L

Mar '26

Rishi Baid

Joint Managing Director

₹17.57 Cr

Mar '26

Vishal Gupta

Non Executive Independent Director

₹22.50 L

Mar '26

Vishal Baid

Executive Director

₹9.51 Cr

Mar '26

Pankaj Kumar Gupta

Executive Director

₹1.05 Cr

Mar '26

Avinash Chandra

Company Secretary & Compliance Officer

—

Ravi Prakash

Deputy Company Secretary

—

POLYMED Latest News

News

4 of 4 articles

EQUITY22 Jun 2026 · 16:59

Poly Medicure submits intimation for schedule of investor meet

EQUITY29 May 2026 · 17:15

Poly Medicure submits transcript of conference call

EQUITY25 May 2026 · 15:21

Poly Medicure reports Profit after tax of Rs 806.22 Mln, in the March 2026 quarter

EQUITY20 May 2026 · 16:58

Poly Medicure informs about conference call

POLYMED

₹1,700.70

-1.04%